Huashan Hospital
Clinical trials sponsored by Huashan Hospital, explained in plain language.
-
MS CAR t trial pulled before it even started
Disease control TerminatedThis early-stage study aimed to test the safety of a new treatment called GC012F for people with multiple sclerosis. The treatment uses specially engineered immune cells (CAR T cells) to target the disease. However, the study was withdrawn before enrolling any participants, so no…
Phase: EARLY_PHASE1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
500 chinese patients join study to unlock secrets of rare muscle disease
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to collect health and genetic information from 500 Chinese adults with myotonic dystrophy type 1 (DM1), a rare inherited muscle disorder. Researchers will measure walking speed and daytime sleepiness to see how the disease affects daily life. The goal is to better…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Can diet slow kidney disease? new study seeks answers
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 1,800 adults with reduced kidney function (not on dialysis) to see how nutrition affects overall health and disease progression. Researchers will track heart health, bone health, thinking skills, and daily function using hospital records and a mobile app. The g…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC